$125.77
1.521.22%
At Close: -
$125.15
-0.62-0.49%
After Hours: Jul 19, 7:41 PM EDT
15 minutes delayed
Comments
Loading...
Merck & Co
MRKNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Merck & Co (NYSE:MRK) Stock, Analyst Ratings, Price Targets, Forecasts
Merck & Co Inc has a consensus price target of $125.62 based on the ratings of 27 analysts. The high is $155 issued by Cantor Fitzgerald on June 20, 2024. The low is $70 issued by Daiwa Capital on December 16, 2021. The 3 most-recent analyst ratings were released by Morgan Stanley, Cantor Fitzgerald, and Cantor Fitzgerald on July 11, 2024, June 20, 2024, and June 18, 2024, respectively. With an average price target of $148 between Morgan Stanley, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 18.26% upside for Merck & Co Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Cantor Fitzgerald
Truist Securities
Berenberg
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Merck & Co
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | Buy Now | 7.07% | Morgan Stanley | Terence Flynn | $132 → $134 | Maintains | Equal-Weight | Get Alert |
| 06/20/2024 | Buy Now | 23.85% | Cantor Fitzgerald | Louise Chen | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 06/18/2024 | Buy Now | 23.85% | Cantor Fitzgerald | Louise Chen | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 06/04/2024 | Buy Now | 23.85% | Cantor Fitzgerald | Louise Chen | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 04/26/2024 | Buy Now | 14.26% | Truist Securities | Robyn Karnauskas | $142 → $143 | Maintains | Buy | Get Alert |
| 04/18/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 04/08/2024 | Buy Now | 14.26% | Berenberg | Luisa Hector | $140 → $143 | Maintains | Buy | Get Alert |
| 04/05/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | Buy Now | 13.46% | Truist Securities | Robyn Karnauskas | $139 → $142 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | — | Reiterates | Overweight → Overweight | Get Alert |
| 03/27/2024 | Buy Now | 7.87% | Wells Fargo | Mohit Bansal | $130 → $135 | Maintains | Equal-Weight | Get Alert |
| 03/11/2024 | Buy Now | -16.9% | Societe Generale | Justin Smith | → $104 | Downgrade | Hold → Sell | Get Alert |
| 03/11/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 02/29/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 02/14/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 02/05/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 02/02/2024 | Buy Now | 11.07% | Truist Securities | Robyn Karnauskas | $122 → $139 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 18.26% | UBS | Colin Bristow | $135 → $148 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 3.88% | Wells Fargo | Mohit Bansal | $125 → $130 | Maintains | Equal-Weight | Get Alert |
| 02/02/2024 | Buy Now | 15.86% | Barclays | Carter Gould | $135 → $145 | Maintains | Overweight | Get Alert |
| 01/23/2024 | Buy Now | 7.87% | Barclays | Carter Gould | $130 → $135 | Maintains | Overweight | Get Alert |
| 01/09/2024 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 01/04/2024 | Buy Now | 7.87% | TD Cowen | Steve Scala | $125 → $135 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/29/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 11/15/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 11/09/2023 | Buy Now | -8.11% | Deutsche Bank | James Shin | → $115 | Initiates | → Buy | Get Alert |
| 10/27/2023 | Buy Now | -5.71% | Morgan Stanley | Terence Flynn | $115 → $118 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | Buy Now | 5.47% | BMO Capital | Evan David Seigerman | → $132 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/23/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 10/11/2023 | Buy Now | -8.11% | Morgan Stanley | Terence Flynn | $116 → $115 | Maintains | Equal-Weight | Get Alert |
| 10/06/2023 | Buy Now | -2.52% | Truist Securities | Robyn Karnauskas | → $122 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 10/02/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 08/02/2023 | Buy Now | -2.52% | Truist Securities | Robyn Karnauskas | $116 → $122 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | -7.31% | Morgan Stanley | Terence Flynn | $109 → $116 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | -7.31% | Truist Securities | Robyn Karnauskas | $118 → $116 | Maintains | Buy | Get Alert |
| 07/14/2023 | Buy Now | -1.72% | HSBC | Rajesh Kumar | → $123 | Initiates | → Hold | Get Alert |
| 07/11/2023 | Buy Now | -12.9% | Morgan Stanley | Terence Flynn | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/30/2023 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 05/01/2023 | Buy Now | 3.08% | Atlantic Equities | Steve Chesney | $127 → $129 | Maintains | Overweight | Get Alert |
| 05/01/2023 | Buy Now | 3.88% | Barclays | Carter Gould | $128 → $130 | Maintains | Overweight | Get Alert |
| 04/13/2023 | Buy Now | 3.88% | Citigroup | Andrew Baum | $105 → $130 | Upgrade | Neutral → Buy | Get Alert |
| 04/11/2023 | Buy Now | -0.92% | Guggenheim | Seamus Fernandez | $123 → $124 | Maintains | Buy | Get Alert |
| 04/10/2023 | Buy Now | 3.88% | Mizuho | Mara Goldstein | → $130 | Reiterates | → Buy | Get Alert |
| 03/17/2023 | Buy Now | 3.88% | Mizuho | Mara Goldstein | → $130 | Reiterates | → Buy | Get Alert |
| 03/13/2023 | Buy Now | -8.11% | Wells Fargo | Mohit Bansal | $120 → $115 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/10/2023 | Buy Now | 3.88% | Berenberg | Luisa Hector | $125 → $130 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 0.68% | Credit Suisse | Trung Huynh | $125 → $126 | Maintains | Outperform | Get Alert |
| 03/07/2023 | Buy Now | 1.48% | Atlantic Equities | Steve Chesney | $122 → $127 | Maintains | Overweight | Get Alert |
| 03/06/2023 | Buy Now | -0.12% | Jefferies | Akash Tewari | → $125 | Initiates | → Buy | Get Alert |
| 02/23/2023 | Buy Now | -0.12% | JP Morgan | Chris Schott | $120 → $125 | Maintains | Overweight | Get Alert |
| 02/22/2023 | Buy Now | 1.48% | Wolfe Research | Tim Anderson | → $127 | Upgrade | Peer Perform → Outperform | Get Alert |
| 02/13/2023 | Buy Now | -0.12% | Credit Suisse | Trung Huynh | $120 → $125 | Maintains | Outperform | Get Alert |
| 02/03/2023 | Buy Now | -4.12% | Wells Fargo | Mohit Bansal | $125 → $120 | Maintains | Overweight | Get Alert |
| 02/03/2023 | Buy Now | -20.89% | Morgan Stanley | Terence Flynn | $100 → $99 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | Buy Now | -5.71% | Truist Securities | Robyn Karnauskas | $106 → $118 | Maintains | Buy | Get Alert |
| 02/03/2023 | Buy Now | -2.52% | SVB Leerink | Daina Graybosch | $120 → $122 | Maintains | Outperform | Get Alert |
| 01/23/2023 | Buy Now | -4.12% | SVB Leerink | Daina Graybosch | $112 → $120 | Maintains | Outperform | Get Alert |
| 01/04/2023 | Buy Now | 3.88% | B of A Securities | Geoff Meacham | $110 → $130 | Upgrade | Neutral → Buy | Get Alert |
| 01/03/2023 | Buy Now | -0.12% | Wells Fargo | Mohit Bansal | $110 → $125 | Maintains | Overweight | Get Alert |
| 12/19/2022 | Buy Now | 7.87% | Cantor Fitzgerald | Louise Chen | $120 → $135 | Maintains | Overweight | Get Alert |
| 11/18/2022 | Buy Now | -4.12% | Credit Suisse | Trung Huynh | → $120 | Initiates | → Outperform | Get Alert |
| 11/01/2022 | Buy Now | -11.31% | Guggenheim | Seamus Fernandez | $104 → $111 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | -12.11% | Barclays | Carter Gould | $105 → $110 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | -20.1% | Morgan Stanley | Terence Flynn | $91 → $100 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | -15.3% | Truist Securities | Robyn Karnauskas | $103 → $106 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | -12.11% | Wells Fargo | Mohit Bansal | $105 → $110 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | -10.51% | SVB Leerink | Jeffrey La Rosa | $110 → $112 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | -2.52% | Atlantic Equities | Steve Chesney | $116 → $122 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | -27.29% | Morgan Stanley | Terence Flynn | $92 → $91 | Maintains | Equal-Weight | Get Alert |
| 10/11/2022 | Buy Now | -7.31% | Atlantic Equities | Steve Chesney | $110 → $116 | Maintains | Overweight | Get Alert |
| 10/10/2022 | Buy Now | — | Guggenheim | Seamus Fernandez | — | Upgrade | Neutral → Buy | Get Alert |
| 09/30/2022 | Buy Now | -12.11% | SVB Leerink | Daina Graybosch | $109 → $110 | Maintains | Outperform | Get Alert |
| 09/14/2022 | Buy Now | -20.1% | Berenberg | Luisa Hector | $95 → $100 | Upgrade | Hold → Buy | Get Alert |
| 09/12/2022 | Buy Now | -12.9% | SVB Leerink | Daina Graybosch | $105 → $109 | Maintains | Outperform | Get Alert |
| 08/25/2022 | Buy Now | — | Erste Group | Hans Engel | — | Upgrade | Hold → Buy | Get Alert |
| 07/29/2022 | Buy Now | -19.3% | Barclays | Carter Gould | $97 → $101 | Maintains | Overweight | Get Alert |
| 07/29/2022 | Buy Now | -26.49% | Morgan Stanley | Terence Flynn | $88 → $92 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | Buy Now | -16.1% | SVB Leerink | Daina Graybosch | $104 → $105 | Maintains | Outperform | Get Alert |
| 07/18/2022 | Buy Now | -21.69% | UBS | Colin Bristow | $76 → $98 | Maintains | Neutral | Get Alert |
| 07/13/2022 | Buy Now | -12.11% | Atlantic Equities | Steve Chesney | $105 → $110 | Maintains | Overweight | Get Alert |
| 07/08/2022 | Buy Now | -29.68% | Morgan Stanley | Terence Flynn | $87 → $88 | Maintains | Equal-Weight | Get Alert |
| 07/07/2022 | Buy Now | -18.5% | Daiwa Capital | Narumi Nakagiri | $89 → $102 | Upgrade | Hold → Outperform | Get Alert |
| 06/27/2022 | Buy Now | -18.5% | Cowen & Co. | Boris Peaker | $95 → $102 | Maintains | Market Perform | Get Alert |
| 04/29/2022 | Buy Now | -30.48% | Morgan Stanley | Terence Flynn | $80 → $87 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | -16.1% | Wells Fargo | Mohit Bansal | $90 → $105 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | -18.5% | SVB Leerink | Daina Graybosch | $97 → $102 | Maintains | Outperform | Get Alert |
| 04/21/2022 | Buy Now | -22.49% | SVB Leerink | Daina Graybosch | $100 → $97 | Maintains | Outperform | Get Alert |
| 04/12/2022 | Buy Now | -22.49% | Barclays | Carter Gould | $94 → $97 | Maintains | Overweight | Get Alert |
| 04/06/2022 | Buy Now | -36.08% | Morgan Stanley | Terence Flynn | $82 → $80 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | Buy Now | -20.1% | SVB Leerink | Daina Graybosch | $101 → $100 | Maintains | Outperform | Get Alert |
| 02/04/2022 | Buy Now | -19.3% | SVB Leerink | Daina Graybosch | $102 → $101 | Maintains | Outperform | Get Alert |
| 01/28/2022 | Buy Now | -24.09% | JP Morgan | Chris Schott | $100 → $95 | Maintains | Overweight | Get Alert |
| 12/16/2021 | Buy Now | -44.07% | Daiwa Capital | — | — | Initiates | → Neutral | Get Alert |
| 12/13/2021 | Buy Now | -39.27% | UBS | Colin Bristow | — | Downgrade | Buy → Neutral | Get Alert |
| 12/09/2021 | Buy Now | -28.09% | Wells Fargo | Mohit Bansal | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Merck & Co (MRK) stock?
The latest price target for Merck & Co (NYSE:MRK) was reported by Morgan Stanley on July 11, 2024. The analyst firm set a price target for $134.00 expecting MRK to rise to within 12 months (a possible 7.07% upside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Merck & Co (MRK)?
The latest analyst rating for Merck & Co (NYSE:MRK) was provided by Morgan Stanley, and Merck & Co maintained their equal-weight rating.
When was the last upgrade for Merck & Co (MRK)?
The last upgrade for Merck & Co Inc happened on January 4, 2024 when TD Cowen raised their price target to $135. TD Cowen previously had a market perform for Merck & Co Inc.
When was the last downgrade for Merck & Co (MRK)?
The last downgrade for Merck & Co Inc happened on March 11, 2024 when Societe Generale changed their price target from N/A to $104 for Merck & Co Inc.
When is the next analyst rating going to be posted or updated for Merck & Co (MRK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Merck & Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Merck & Co was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
Is the Analyst Rating Merck & Co (MRK) correct?
While ratings are subjective and will change, the latest Merck & Co (MRK) rating was a maintained with a price target of $132.00 to $134.00. The current price Merck & Co (MRK) is trading at is $125.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.